Sturm, Ruger & Company, Inc. (RGR) SEC Filings & Earnings Calls
EquiReason read 32 Sturm, Ruger & Company, Inc. SEC filings in the last 12 months. Latest: SC 13D/A on 2026-10-20 — Beretta Holding S.A. increased its stake in Sturm, Ruger & Co. to 25.0% via a tender offer, paying $44.80 per share for 2,400,184 shares..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 726.5M
- P/E TTM
- 60.6
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
17 Sep 2026SC 13D/ABeretta Holding S.A. filed Amendment No. 7 to Schedule 13D, disclosing commencement of a tender offer to purchase up to 2,400,184 shares of Sturm, Ruger & Co. at $44.80 per share, increasing its beneficial ownership to ~24.95%.open
Figures in the filing · each found in the filing text
| Beneficial ownership percentage · 2026-09-17 | 9.9% | |
| Tender offer shares · 2026-09-17 | 2,400,184 | |
| Tender offer price per share · 2026-09-17 | $44.80 | |
| Pro forma beneficial ownership percentage · 2026-09-17 | 24.9% |
Risks flagged
Tender offer may not be fully subscribed
“The Tender Offer is not conditioned on any minimum number of Shares being tendered.”
16 Sep 20268-K · 1.01, 1.02, 3.03, 7.01Sturm Ruger & Company terminated its shareholder rights plan (poison pill) early after satisfying regulatory conditions under its Strategic Cooperation Agreement with Beretta Holding. Indicates reduced takeover defense.open
Risks flagged
Reduced takeover defense may increase vulnerability to hostile acquisition.
“Termination of the rights plan removes a key anti-takeover measure.”
31 Jul 20268-K · 7.01Net Sales $158M (+19% y/y); Adjusted EBITDA Margin 10.5; Diluted Earnings Per Share $0.43; Guidance: 5th consecutive quarter of growth; manufacturing improvements; accessory expansionopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $158M | +19% y/y |
| Adjusted EBITDA Margin · Q2-2026 | 10.5% | |
| Diluted Earnings Per Share · Q2-2026 | $0.43 | |
| Adjusted Diluted EPS · Q2-2026 | $0.52 | |
| Cash from Operations · Q2-2026 | $17M | |
| Dividend per Share · Q2-2026 | $0.21 |
Guidance
5th consecutive quarter of growth; manufacturing improvements; accessory expansion
Strong sales growth, margin expansion, and operational improvements; management tone positive
Risks flagged
Prior production constraints limiting ability to meet demand; now improving
“During our first quarter call, we discussed production constraints that limited our ability to fully meet customer demand” · word for word
29 Jul 20268-K · 2.02Net sales $158M (+19% y/y); Diluted earnings per share $0.43; Adjusted diluted earnings per share $0.52earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $158M | +19% y/y |
| Diluted earnings per share · Q2-2026 | $0.43 | |
| Adjusted diluted earnings per share · Q2-2026 | $0.52 | |
| Average selling price · Q2-2026 | $384.00 | +10% y/y |
| Net Income Margin · Q2-2026 | 4.4% | |
| Adjusted EBITDA Margin · Q2-2026 | 10.5% | |
| Cash from operations · Q2-2026 | $17M | |
| Dividend per share · Q2-2026 | $0.21 | |
| New product sales · Firearm · H1-2026 | $81M |
Risks flagged
Strategic cooperation agreement with Beretta Holding introduces potential governance and strategic risks.
“Incurred incremental expenses associated with negotiating and finalizing the Strategic Cooperation Agreement with Beretta Holding S.A.” · word for word
CFO transition costs incurred in the quarter.
“one-time expenses related to the transition of the Chief Financial Officer that were incurred in the quarter.” · word for word
29 Jul 202610-QSturm, Ruger reported a strong Q2 2026 with net sales up 19.3% YoY, gross margin improving to 21.3% from 3.9%, and a return to profitability with net income of $7.0 million.earningsopen
Figures in the filing · each found in the filing text
| Total net sales · Q2-2026 | $158M | +19% y/y |
| Net income (loss) · Q2-2026 | $7M | +141% y/y |
| Adjusted EBITDA · Q2-2026 | $17M | +205% y/y |
| Ending backlog · Q2-2026 | $331M | +26% y/y |
| Operating cash flow · H1-2026 | $36M | +39% y/y |
Risks flagged
Raw material supply risk
“A limited supply of these materials in the marketplace can result in increases to purchase prices and adversely affect production levels.” · word for word
Regulatory risk
“If these regulations become more stringent in the future and the Company is not able to comply with them, such noncompliance could have a material adverse impact on the Company.” · word for word
8 May 20268-K · 7.01Net sales $141M (+4% y/y); Diluted EPS $0.01 (-98% y/y); Adjusted diluted EPS $0.27open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $141M | +4% y/y |
| Diluted EPS · Q1-2026 | $0.01 | -98% y/y |
| Adjusted diluted EPS · Q1-2026 | $0.27 | |
| Units ordered · Q1-2026 | 525,000 | +28% y/y |
| Backlog · Q1-2026 | $330M | +20% y/y |
| New product sales · Q1-2026 | $52M | |
| Cash from operations · Q1-2026 | $19M | |
| Capital expenditures · Q1-2026 | $5M | |
| Dividend per share · Q1-2026 | $0.11 |
Risks flagged
GAAP EPS significantly lower than adjusted due to one-time costs
“Diluted earnings were $0.01 per share compared to $0.46 per share in prior year; adjusted $0.27” · word for word
6 May 20268-K · 2.02Net Sales $141M (+4% y/y); Adjusted Earnings per Share $0.27 (-41% y/y); Cash from Operations $19M; Guidance: Capex $30M for FY2026earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $141M | +4% y/y |
| Adjusted Earnings per Share · Q1-2026 | $0.27 | -41% y/y |
| Cash from Operations · Q1-2026 | $19M | |
| New Product Sales · Firearm · Q1-2026 | $52M | |
| Capital Expenditures · Q1-2026 | $5M | |
| Dividend per Share · Q1-2026 | $0.11 | |
| Cash and Short-term Investments · Q1-2026 | $105M |
Guidance
Capex $30M for FY2026
Management positive on demand and innovation; expects improved profitability as temporary costs roll off; capex guidance maintained.
Risks flagged
One-time expenses from Beretta agreement and restructuring may recur in near term.
“Additional Agreement-related expenses may be incurred in the near term.” · word for word
Adjusted EPS decline of 41% YoY indicates underlying profitability pressure despite revenue growth.
“Adjusted EPS $0.27 vs $0.46 prior year.”
6 May 202610-QNet sales $141M (+4% y/y); Gross margin 19.9; Adjusted EBITDA $11M (-24% y/y); Guidance: Capex guided $20M-$30M for FY2026; no revenue or margin guidanceopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $141M | +4% y/y |
| Gross margin · Q1-2026 | 19.9% | |
| Adjusted EBITDA · Q1-2026 | $11M | -24% y/y |
| Operating cash flow · Q1-2026 | $19M | +69% y/y |
| Capital expenditures · Q1-2026 | $5M | +336% y/y |
| Ending backlog · Q1-2026 | $330M | |
| Units ordered · Q1-2026 | 525,300 | +28% y/y |
| Units shipped · Q1-2026 | 375,600 | +5% y/y |
| New product sales · Q1-2026 | $52M | |
| Adjusted NICS background checks · Q1-2026 | 3,877,000 | +2% y/y |
Guidance
Capex guided $20M-$30M for FY2026; no revenue or margin guidance
Capex guided higher ($20M-$30M), demand accelerating (sell-through +3.2% vs NICS +1.6%), but margin under pressure from one-time costs and fixed cost deleverage.
Risks flagged
Raw material supply disruption
“If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.” · word for word
Regulatory compliance cost
“If these regulations become more stringent in the future and the Company is not able to comply with them, such noncompliance could have a material adverse impact on the Company.” · word for word
4 May 2026SC 13D/ABeretta Holding S.A. files Amendment No. 6 to Schedule 13D, disclosing an agreement with Sturm, Ruger & Company, Inc. to appoint two directors and launch a tender offer for up to 15.05% of shares at $44.80 per share.open
Figures in the filing · each found in the filing text
| Beneficial Ownership · 2026-05-02 | 9.9% |
Risks flagged
Regulatory Approval Risk
“The Tender Offer is subject to satisfaction of certain Regulatory Conditions (as defined in the Agreement).”
4 May 20268-K · 1.01, 7.01Sturm, Ruger & Beretta Holding entered a Strategic Cooperation Agreement: Beretta can increase ownership to 25% at $44.80/share (~20% premium), nominate up to 2 directors, with a 3-year standstill. Ruger remains independent.open
Risks flagged
Potential dilution from tender offer and board influence by large shareholder.
“Beretta Holding's right to designate directors and tender offer conditions.”
4 May 2026SC 13D/ABeretta Holding S.A. files Amendment No. 6 to Schedule 13D, disclosing an agreement with Sturm, Ruger & Company, Inc. to appoint two directors and launch a tender offer for up to 15.05% of shares at $44.80 per share.open
Figures in the filing · each found in the filing text
| Beneficial Ownership · 2026-05-02 | 9.9% |
Risks flagged
Regulatory Approval Risk
“The Tender Offer is subject to satisfaction of certain Regulatory Conditions (as defined in the Agreement).”
31 Mar 2026SC 13D/ABeretta Holding disclosed a rejected premium tender offer for up to 20.05% of Sturm Ruger at $44.80/share and is considering litigation against the board.open
Risks flagged
Poison pill defense may block value realization
“the Issuer rejected the Reporting Person's request for an exemption under the Issuer's "poison pill" rights plan” · word for word
31 Mar 2026SC 13D/ABeretta Holding disclosed a rejected premium tender offer for up to 20.05% of Sturm Ruger at $44.80/share and is considering litigation against the board.open
Risks flagged
Poison pill defense may block value realization
“the Issuer rejected the Reporting Person's request for an exemption under the Issuer's "poison pill" rights plan” · word for word
25 Mar 2026SC 13D/ABeretta Holding S.A. disclosed a letter to Sturm Ruger's board expressing intent to commence a tender offer for up to 20.05% of outstanding shares at $44.80 per share, a ~20% premium.being acquiredopen
Figures in the filing · each found in the filing text
| Beneficial ownership percentage · 2026-03-25 | 9.9% |
25 Mar 2026SC 13D/ABeretta Holding S.A. disclosed a letter to Sturm Ruger's board expressing intent to commence a tender offer for up to 20.05% of outstanding shares at $44.80 per share, a ~20% premium.being acquiredopen
Figures in the filing · each found in the filing text
| Beneficial ownership percentage · 2026-03-25 | 9.9% |
9 Mar 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Potential proxy contest or activist pressure from Beretta Holding.
“Beretta Holding nominated director candidates for the 2026 annual meeting.”
4 Mar 20268-K · 7.01Net sales $151M (+4% y/y); Diluted earnings per share $0.21 (-66% y/y); Net sales (full year) $546M (+2% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q4-2025 | $151M | +4% y/y |
| Diluted earnings per share · Q4-2025 | $0.21 | -66% y/y |
| Net sales (full year) · FY2025 | $546M | +2% y/y |
| Net loss per share (full year) · FY2025 | $-0.27 | |
| Cash and short-term investments · Q4-2025 | $93M | |
| Cash from operations (full year) · FY2025 | $54M | |
| Capital expenditures · FY2025 | $31M | |
| Dividend per share · Q4-2025 | $0.08 |
Risks flagged
Consumer discretionary spending pressure and industry demand normalization.
“Inflationary pressures, discretionary spending constraints and a normalization of demand” · word for word
Restructuring and product rationalization costs impacting margins.
“rationalized and price-repositioned several product lines, reduced the number of models offered and implemented an organizational realignment” · word for word
2 Mar 202610-KNet sales $546M (+2% y/y); Net income (loss) $-4M (-114% y/y); Gross margin 14.9; Guidance: Capex guidance: ~$30 million in 2026open
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $546M | +2% y/y |
| Net income (loss) · FY2025 | $-4M | -114% y/y |
| Gross margin · FY2025 | 14.9% | |
| EBITDA · FY2025 | $30M | -46% y/y |
| EBITDA margin · FY2025 | 5.4% | |
| Ending backlog · FY2025 | $285M | +13% y/y |
| Units shipped · FY2025 | 1,504,000 | +7% y/y |
| Units produced · FY2025 | 1,456,300 | +6% y/y |
| Units ordered · FY2025 | 1,602,700 | +13% y/y |
| Average sales price · FY2025 | $364.00 | -3% y/y |
Guidance
Capex guidance: ~$30 million in 2026
Capital expenditure guidance provided for 2026 (~$30M), but no revenue or earnings guidance. Backlog increased, suggesting some demand visibility.
Risks flagged
Firearms Legislation Risk
“If the scope of the National Firearms Act is expanded to regulate firearms currently regulated by the Gun Control Act, it could make acquisition of commonly owned and used firearms more expensive and complicated for consumers, which could have a material adverse impact on demand for Company products.” · word for word
Distributor Concentration Risk
“Over 90% of the Company’s sales are made to 13 federally licensed, independent wholesale distributors.” · word for word
Raw Material Cost Risk
“If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.” · word for word
Activist Stockholder Risk
“The Company has been and may continue to be subject to actions from activist stockholders or others that may not align with its business strategies or may not be in the best interests of all of its stockholders.” · word for word
2 Mar 20268-K · 2.02Net sales $151M (+4% y/y); Net sales (full year) $546M (+2% y/y); Diluted earnings per share $0.21 (-66% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q4-2025 | $151M | +4% y/y |
| Net sales (full year) · FY2025 | $546M | +2% y/y |
| Diluted earnings per share · Q4-2025 | $0.21 | -66% y/y |
| Diluted earnings per share (full year) · FY2025 | $-0.27 | -115% y/y |
| Adjusted diluted earnings per share · FY2025 | $0.84 | -55% y/y |
| Cash generated from operations · FY2025 | $54M | |
| Cash and short-term investments · FY2025 | $93M | |
| Capital expenditures · FY2025 | $31M | |
| Dividend per share · Q4-2025 | $0.08 | |
| Share repurchases · FY2025 | $26M |
Risks flagged
Significant profitability decline despite revenue growth; cost pressures and restructuring needed.
“Diluted EPS dropped from $0.62 to $0.21; full-year net loss per share ($0.27) vs earnings $1.77.”
Challenging consumer environment and declining NICS background checks.
“Despite a 4.1% decrease in adjusted NICS during the same period.” · word for word
Dividend cut indicates management caution.
“Dividend of $0.08 per share, equates to approximately 40% of net income.”
7 Nov 20258-K · 7.01Net Sales $127M (+4% y/y); Diluted Earnings Per Share $0.10 (-64% y/y); Cash and Short-Term Investments $81Mopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $127M | +4% y/y |
| Diluted Earnings Per Share · Q3-2025 | $0.10 | -64% y/y |
| Cash and Short-Term Investments · Q3-2025 | $81M | |
| Capital Expenditures · 9M-2025 | $28M | |
| Cash from Operations · 9M-2025 | $39M |
Risks flagged
Macroeconomic headwinds from tariffs, interest rates, inflation, and softening job market
“The broader market continues to face headwinds from tariff and interest rate uncertainty, inflationary pressures and a softening job market” · word for word
Used firearm availability impacting new product demand
“the market continues to be influenced by the availability of used firearms at retail” · word for word
5 Nov 202510-QQ3 2025 results: revenue up 3.7% YoY but gross margin fell 340bps, net income down 66.6%, and company swung to a net loss for the nine-month period due to restructuring charges.earningsopen
Figures in the filing · each found in the filing text
| Net firearms sales · Firearms · Q3-2025 | $126M | +4% y/y |
| Total net sales · Q3-2025 | $127M | +4% y/y |
| Gross profit · Q3-2025 | $19M | -16% y/y |
| Gross margin · Q3-2025 | 15.1% | |
| EBITDA margin · Q3-2025 | 2.2% | |
| Ending backlog · Q3-2025 | $227M | -16% y/y |
| Units shipped · Q3-2025 | 361,600 | +10% y/y |
| Average sales price of units shipped · Q3-2025 | $336.00 | -9% y/y |
| Operating cash flow · 9M-2025 | $39M | +9% y/y |
Risks flagged
Activist shareholder pressure
“The Board, in consultation with its advisors, adopted the Rights Plan in response to the public announcement by Beretta Holding S.A. (“Beretta”) that it had accumulated a significant economic interest in Ruger’s common stock and intends to engage in discussions with the Company regarding “potential areas of operational and strategic collaborations”.” · word for word
Margin compression
“Gross margin decreased from 18.5% to 15.1% due to inventory write-offs, product mix shift, and higher costs.”
Demand weakness
“NICS background checks decreased 4.3% in the first nine months of 2025 compared to the prior year period.”
5 Nov 20258-K · 2.02Net sales $127M (+4% y/y); Diluted earnings per share $0.10 (-64% y/y); Cash generated from operations $13Mearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $127M | +4% y/y |
| Diluted earnings per share · Q3-2025 | $0.10 | -64% y/y |
| Cash generated from operations · Q3-2025 | $13M | |
| New product sales · Q3-2025 | $41M | |
| Capital expenditures · 9M-2025 | $28M | |
| Cash and short-term investments · Q3-2025 | $81M | |
| Dividend per share · Q3-2025 | $0.04 |
Risks flagged
Acquisition integration costs and facility ramp-up expenses are pressuring margins.
“$1.9 million of acquisition and operating costs at the new Hebron, KY facility.” · word for word
Increased material and technology costs, along with promotional expenses, are eroding profitability.
“increased costs associated with material and technology, and increased sales promotional expenses.” · word for word
Restructuring and product line rationalization may continue to impact near-term results.
“rationalized and price-repositioned several product lines, reduced the number of models offered and implemented an organizational realignment.” · word for word
Sturm, Ruger & Company, Inc. — questions
- What did Sturm, Ruger & Company, Inc. file recently?
- 32 SEC filings in the last 12 months. Latest: SC 13D/A on 2026-10-20 — Beretta Holding S.A. increased its stake in Sturm, Ruger & Co. to 25.0% via a tender offer, paying $44.80 per share for 2,400,184 shares.
Every figure on this page comes from Sturm, Ruger & Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.